Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on February 23, 2009

Circulation. 2009
Published online before print February 23, 2009, doi: 10.1161/CIRCULATIONAHA.108.845552
A more recent version of this article appeared on March 10, 2009
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
119/9/1186    most recent
CIRCULATIONAHA.108.845552v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eikelboom, J. W.
Right arrow Articles by Weitz, J. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eikelboom, J. W.
Right arrow Articles by Weitz, J. I.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Blood Thinners
*Heart Attack
Related Collections
Right arrow Heparin
Right arrow Other anticoagulants
Right arrow Acute myocardial infarction

Submitted on ,
Accepted on ,

Anticoagulation for ST-Segment Elevation Myocardial Infarction

John W. Eikelboom MD* and Jeffrey I. Weitz MD

From the Departments of Medicine (J.W.E., J.I.W.) and Biochemistry and Medical Sciences (J.I.W.), McMaster University and Henderson Research Centre, Hamilton, Ontario, Canada.

* To whom correspondence should be addressed. E-mail: eikelbj{at}mcmaster.ca.


Key words: Editorials • anticoagulants • heparin • myocardial infarction